Kevin Maskell

Founder, CEO & CSO of Bioarchitech. Kevin is the inventor of Bioarchitech’s core technologies. With >20 years immunology, virology and oncology experience spanning from academia (University of Oxford) to industry both small (Oxford spin-outs BioAnaLab and Oxford Cancer Biomarkers) and large (Merck Millipore) has given him a comprehensive view of the whole drug discovery life cycle.